twitter twitter

Bio Ascend

17th Atlanta Lung Cancer Symposium Agenda

Saturday, October 28, 2023

7:00 AM
Breakfast Symposium
7:55 AM
Welcome and Introductions
Suresh Ramalingam, MD, FACP, FASCO
Kristin Higgins, MD
Ticiana A. Leal, MD

Plenary 1: Early-Stage NSCLC

Co-Chairs: Ticiana Leal, MD, and Ioana Bonta, MD

8:00 AM
Perioperative Immunotherapy in NSCLC
Tina Cascone, MD, PhD

8:20 AM

Surgical Considerations in Neoadjuvant Immunotherapy in NSCLC
Felix G. Fernandez, MD, MSc
8:40 AM
Adjuvant TKI Therapy in NSCLC
Gregory Riely, MD, PhD

8:55 AM

Role of RT in Early-Stage NSCLC
Kristin Higgins, MD

9:15 AM

Use of ctDNA in Early-Stage NSCLC
Valsamo Anagnostou, MD, PhD

9:35 AM

Panel Discussion

9:55 AM

Morning Break and Exhibits

Plenary 2: Unresectable Locally Advanced NSCLC/Oligometastatic NSCLC

Co-Chairs: Mohan Krishnamachary, MD, and Kristin Higgins, MD

10:15 AM

Ticiana Leal, MD

10:35 AM

Consolidation RT in Oligometastatic NSCLC
Sibo Tian, MD

10:55 AM

DEBATE: Targeted Therapy in Stage III NSCLC – Yes or No?
Yes: Jyoti D. Patel, MD
No: Stephen Liu, MD

11:35 AM

Panel Discussion

11:55 AM

Lunch Symposium

Plenary 3: Immunotherapy in Advanced NSCLC

Co-Chairs: William Jonas, MD, and Jennifer Carlisle, MD

12:45 PM

Updates in Frontline Immunotherapy in NSCLC
Paul Bunn, MD

1:05 PM

Emerging Strategies in IO-Resistant NSCLC
Ticiana Leal, MD

1:25 PM

Novel Treatment Approaches in SCLC

Taofeek Owonikoko, MD, PhD

1:45 PM

Panel Discussion

2:05 PM

Afternoon Break and Exhibits

Plenary 4: Targeted Therapies in Advanced NSCLC

Co-Chairs: Paul Gill, MD, and Michael Andrews, MD

2:25 PM

Updates in EGFR NSCLC

Suresh Ramalingam, MD, FACP, FASCO

2:40 PM

EGFR Exon 20 and EGFR Uncommon Mutations in NSCLC

Jennifer W. Carlisle, MD

2:55 PM

KRAS NSCLC and Combinations to Overcome Resistance

John V. Heymach, MD, PhD

3:10 PM


Conor E. Steuer, MD

3:25 PM


Ibiayi Dagogo-Jack, MD

3:40 PM

Panel Discussion

3:55 PM

Closing Remarks and Adjourn

This website uses cookies to ensure you get the best experience on our website.